014570 — Korean Drug Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapContrarian

Annual balance sheet for Korean Drug Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	22,230	27,881	26,416	16,756	19,000
Net Total Accounts Receivable
Net Total Receivables	27,894	28,983	31,460	28,008	22,891
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	62,956	70,450	72,617	63,426	62,925
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13,784	13,999	18,607	22,999	22,054
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	83,345	88,613	94,516	89,709	88,887
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9,771	10,329	7,412	9,902	7,210
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	12,474	11,923	9,804	12,619	10,781
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	70,871	76,690	84,713	77,090	78,106
Total Liabilities & Shareholders' Equity	83,345	88,613	94,516	89,709	88,887
Total Common Shares Outstanding